Thomson Reuters, a distinguished brokerage company, has placed a 52-week price target of $26.40 on Phibro Animal Health Corporation (NASDAQ:PAHC) shares after it surveyed top market analysts. Calculating estimated earnings after taking into consideration different elements, it is predicted to come at $1.60 for the next fiscal and $N/A for underway quarter. Valuation Estimates Analysts take into account the price to earnings ratio to estimate the firm’s valuation. This ratio, which is also called as the P/E ratio evaluates the company on relative expense factor. The formula to calculate ratio is stock’s latest price/ per share earnings. The P/E ratio of Phibro Animal Health Corporation (NASDAQ:PAHC) stands at 10.62. Analysts also work out Price/Earnings Growth ratio in an attempt to estimate the valuation of a firm. This ratio commonly known as the PEG ratio implies the stock’s valuation compared to earnings growth potential. Investors look to invest in the stocks with a lower PEG ratio. For Phibro Animal Health Corporatio, the PEG ratio for coming 3-5 years is 3.49. Technical Analysis The technical analysis highlights that Phibro Animal Health Corporatio current price is trading $0.95 points away +4.81% from $19.76, which stands as the 50-day moving average of the firm. The stock’s 200-day MA is $23.89 and, for now, the stock price is trading $-3.18 or -13.29% away from that point. The 52-week high of Phibro Animal Health Corporation (NASDAQ:PAHC) was $40.40 while lowest point recorded in 52-week was $16.80. It implies if stock price makes a movement of over $-19.69, it will record a new 52-week high. In the case of $+23.27% points drop, it will touch a new 52-week low.
1 Chart Pattern Every Investor Should Know